ENTX
Entera Bio Ltd
2.90$
-0.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 0.0% | 189.8% | 57.3% | 65.3% | 75.4% | 400.0% | 95.0% | 100.0% | |
| – | – | – | 100.0% | -89.8% | 42.7% | 34.7% | 24.6% | -400.0% | 5.0% | -71.4% | |
| – | – | – | 1,703.6% | 2,949.6% | 1,752.9% | 1,185.8% | 4,364.2% | 31,814.3% | 2,485.6% | 14,295.2% | |
| – | – | – | 568.6% | 1,814.0% | 1,340.0% | 996.5% | 5,412.7% | 31,642.9% | 2,814.9% | 13,154.8% | |
| – | – | – | 2,272.2% | 4,763.6% | 3,092.9% | 2,174.3% | 9,738.8% | 63,457.1% | 5,300.6% | 27,450.0% | |
| – | – | – | -2,172.2% | -4,853.4% | -3,050.1% | -2,139.6% | -9,714.2% | -63,857.1% | -5,295.6% | -27,450.0% | |
| – | – | – | 0.0% | 35.6% | 382.2% | 5.1% | 19,404.5% | – | – | – | |
| – | – | – | -2,060.8% | -4,574.2% | -2,729.6% | -2,144.7% | -9,652.2% | -63,285.7% | -5,263.5% | -27,235.7% | |
| – | – | – | 111.4% | 35.6% | 5.5% | -10.3% | 102.2% | 207.1% | 7.7% | 27,450.0% | |
| – | – | – | -2,060.8% | -4,574.2% | -2,735.1% | -2,134.3% | -9,754.5% | -63,492.9% | -5,271.3% | -27,235.7% | |
| – | – | – | -2,161.4% | -4,437.7% | -2,988.5% | -2,130.3% | -9,666.4% | -62,885.7% | -5,238.1% | -27,164.3% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.